 | ChromaDex Corporation | |||
| NCM : CDXC || Location: United States | ||||
$3.4+0.45 (+15.25%) |
0.3 M | 2.94 - 3.44 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 1.316 M |
| March 15, 2024 | 1.174 M |
| Feb. 29, 2024 | 1.210 M |
| Feb. 15, 2024 | 1.325 M |
| Jan. 31, 2024 | 1.298 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | -0.03 | -0.01 | 69.88% |
| 06/30/2023 | -0.04 | -0.03 | 21.67% |
| 03/31/2023 | -0.05 | -0.03 | 38.78% |
| 12/31/2022 | -0.02 | -0.02 | 19.03% |
| 09/30/2022 | -0.06 | -0.01 | 83.30% |
CDXC Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 75.309M | Shares Float | 51.401M |
| Short Float | 1.316M | Market Cap | 222.16M |
| Institution ownership | 16.13% | Insider ownership | 41.186% |
| Earnings Date | 05/09/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -0.07 | Forward EPS | 0.05 |